Biomagnetics Diagnostics Corp., (Pink Sheets:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, recently announced in November that the Company will hold an investor conference call to discuss upcoming business opportunities and its agreement with Los Alamos National Security, one of the world’s premiere research laboratories.

Specifically, the call, which will be open to all investors, will be held on Wednesday, December 2nd at 4:30 EST. Interested parties may dial into the Biomagnetics Diagnostics Corp. conference call using the toll free dial-in number (US & Canada) of (888) 858-6021 or the local toll dial-in number of (973) 935-2037. The conference pass code to access the call is 5913680359.

“It is a very exciting time for all of us at Biomagnetics as well as our shareholders. For the past few quarters, we have been working on several major growth initiatives that are now coming to fruition,” commented Clayton Hardman, CEO of Biomagnetics Diagnostics. “Please join us on tomorrow’s investor conference call as we discuss the pending introduction of our revolutionary technologies for malaria, HIV, tuberculosis and other pathogen and disease diagnosis and as we profile our new and evolving relationship with one of the world’s premiere research institutions, Los Alamos National Security. We view our current business opportunities as being highly significant.”

The Company recently announced on November 30th that it has finalized a “Patent License Agreement with Los Alamos National Security.” Under the agreement, Biomagnetics will have access to the Triggered Optical Biosensor and Integrated Optical Biosensor System (IBOS) technology developed at Los Alamos National Laboratory.

According to the World Health Organization, some 3.2 billion people, or about half of the world’s population is at risk of malaria transmission in 107 countries and territories worldwide. While there are between 350 million and 500 million new cases of malaria each year, there are very few reliable and field deployable diagnostic tools available. In the case of malaria, early detection substantially improves treatability and survivability. Field deployable Integrated Optical Biosensor System (IBOS), such as those Biomagnetics Diagnostics is planning to soon introduce, hold the promise to significantly speed the diagnostic testing process and to meaningfully lower costs and improve lives.

Source
Biomagnetics Diagnostics Corp.

Related posts:

1. Quintiles Increases Capacity To Manage Clinical Studies For Diseases Including Malaria, HIV And Tuberculosis To improve efficiency and expand capacity to monitor the growing...
2. Local Charity Calls For People Living With HIV Across The County To Give Their Views At A Major HIV Conference In Eastbourne HIV and sexual health charity Terrence Higgins Trust (THT) has...
3. The AIDS Institute, Nobel Prize Winner Join On World AIDS Day To Call For More Therapeutic Vaccine Funding In honor of World AIDS Day, The AIDS Institute (TAI),...
4. Not-for-Profit Targets HIV/Tuberculosis Co-Epidemic And Black Lung With Remote X-ray Screening Solution The World Health Imaging, Telemedicine and Informatics Alliance (WHITIA) today...
5. No More ‘Bottom’ Of The Class Thanks To New THT Campaign, UK Terrence Higgins Trust is launching a new campaign today teaching...

Related posts brought to you by Yet Another Related Posts Plugin.

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment

You must be logged in to post a comment.